Repeated courses of certain antibiotics associated with increased diabetes risk
the ONA take:
Repeated use of penicillins, cephalosporins, quinolones, and macrolides may increase people's risk of developing type 2 diabetes by changing their gut flora, a recent study published in the European Journal of Endocrinology has shown.
Researchers from the Departments of Gastroenterology and Medical Oncology at the University of Pennsylvania in Philadelphia, Pennsylvania, analyzed data from over 200,000 diabetics in the UK prescribed antibiotics in the years before diagnosis and compared the number of antibiotic prescriptions to the number prescribed to 800,000 non-diabetics.
Results showed that patients who were prescribed at least two courses of penicillins, cephalosporins, quinolones, and macrolides were at an increased risk of being diagnosed with type 2 diabetes.
Researchers also found that the risk increased with repeated antibiotic courses. The researchers suggest that the association between antibiotic use and diabetes may be due to antibiotics altering the diversity of gut bacteria.
Researchers found no that suggests anti-virals or anti-fungals increase the risk of type 2 diabetes and minimal evidence to support a link between antibiotics and an increased risk of type 1 diabetes.
The findings emphasize the necessity to decrease the number of unnecessary antibiotic prescriptions.
Repeated use of antibiotics may increase people's risk of developing type 2 diabetes by changing their gut flora.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|